Back
Novartis AG Quote, Financials, Valuation and Earnings
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
65
NVSEF
Novartis AG
Last Price:
104.95
Seasonality Move:
2.1%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeNovartis AG Price Quote
$104.95
Novartis AG Key Stats
Buy
65
Novartis AG (NVSEF)
is a Buy
Day range:
$104.95 - $105.00
52-week range:
$90.24 - $123.55
Dividend yield:
3.56%
P/E ratio:
14.78
P/S ratio:
4.31
P/B ratio:
4.84%
Volume:
60.5K
Avg. volume:
10.2K
1-year change:
14.39%
Market cap:
$209.8B
Revenue:
$46.7B
EPS:
$8.53
How Much Does Novartis AG Make?
-
How Much Are Novartis AG's Sales Annually?
NVSEF Revenues are $46.7B -
How Much Profit Does Novartis AG's Make A Year?
NVSEF net income is $14.9B
Is Novartis AG Growing As A Company?
-
What Is Novartis AG's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.09% -
What Is Novartis AG's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.85%
Novartis AG Stock Price Performance
-
Did Novartis AG Stock Go Up Last Month?
Novartis AG share price went down by -9.29% last month -
Did NVSEF's Share Price Rise Over The Last Year?
NVSEF share price rose by 14.39% over the past 1 year
What Is Novartis AG 52-Week High & Low?
-
What Is Novartis AG’s 52-Week High Share Price?
Novartis AG has traded as high as $123.55 over the past 52 weeks -
What Is Novartis AG’s 52-Week Low Share Price?
Novartis AG has traded as low as $90.24 over the past 52 weeks
Novartis AG Price To Free Cash Flow
-
Is Novartis AG Stock Overvalued?
Novartis AG is trading at a price to free cash flow ratio of 17.21 -
Is Novartis AG Stock Undervalued?
Novartis AG EV to Free Cash Flow ratio is 18.09 -
What Is Novartis AG’s Price Earnings Growth Ratio?
NVSEF PEG ratio is 0.10 -
Is Novartis AG Trading At A Premium To Earnings?
Novartis AG EV to EBIT ratio is 16.54
Is It Risky To Buy Novartis AG?
-
How Much Debt Does Novartis AG Have?
Total long term debt quarterly is $30.3B -
How Much Cash Does Novartis AG Have?
Cash and short term investments quarterly total is $14B -
What Is Novartis AG’s Book Value Per Share?
Book value per share is 21.67
Is Novartis AG Cash Flow Positive?
-
What Is NVSEF Cash Flow From Operations?
Cash flow from operations (TTM) is $16B -
What Is Novartis AG’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$9.4B -
What Is Novartis AG’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.2B
Novartis AG Return On Invested Capital
-
Is Management Doing A Good Job?
NVSEF return on invested capital is 25.8% -
What Is Novartis AG Return On Assets?
ROA measures how assets are converting to revenues and is 17.33% -
What Is NVSEF Return On Equity?
ROE is a measure of profitability and is 41.89%
Novartis AG Earnings Date & Stock Price
-
What Is Novartis AG's Stock Price Today?
A single share of NVSEF can be purchased today for 104.95 -
What Is Novartis AG’s Stock Symbol?
Novartis AG trades on the otcm under the ticker symbol: NVSEF -
When Is Novartis AG’s Next Earnings Date?
The next quarterly earnings date for Novartis AG is scheduled on November 14, 2024 -
When Is NVSEF's next ex-dividend date?
Novartis AG's next ex-dividend date is March 7, 2024 -
How To Buy Novartis AG Stock?
You can buy Novartis AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novartis AG Competitors
-
Who Are Novartis AG's Competitors?
Below is a list of companies who compete with Novartis AG or are related in some way:
Novartis AG Dividend Yield
-
What Is NVSEF Dividend Yield?
Novartis AG’s dividend yield currently is 3.56% -
What Is Novartis AG’s Payout Ratio?
Novartis AG’s payout ratio is 43.31% -
When Did Novartis AG Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Novartis AG’s Dividend Per Share?
Novartis AG pays a dividend of $0.00 per share
Novartis AG Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 84.71% | 0% |
| Revenue: | 8.93% | 1.24% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 83.00 |
| Downside from Last Price: | -20.91% |